Improving fundamentals and sell-side upgrades break Cardinal Health (CAH) higher from base building support

CAH has risen from its base fueled by a UBS upgrade and additional fundamental improvements in the company outlook. Longer term, the technical picture seems to offer a
reasonable risk/reward at these levels. Prior
to the break, RSI numbers were resting in the 40 range while MACD momentum held firm as prices eroded lower. Now daily momentum has risen to new highs creating a new target price of : $70.89 (Sept '06 high). Stop loss 63.10.